These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 25198786)

  • 41. Interaction between cardiotonic steroids and Na,K-ATPase. Effects of pH and ouabain-induced changes in enzyme conformation.
    Cornelius F; Mahmmoud YA
    Biochemistry; 2009 Oct; 48(42):10056-65. PubMed ID: 19778013
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Na/K-ATPase mimetic pNaKtide peptide inhibits the growth of human cancer cells.
    Li Z; Zhang Z; Xie JX; Li X; Tian J; Cai T; Cui H; Ding H; Shapiro JI; Xie Z
    J Biol Chem; 2011 Sep; 286(37):32394-403. PubMed ID: 21784855
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human myocardial and skeletal muscular Na,K-ATPase in relation to digoxin therapy of heart failure.
    Schmidt TA
    Dan Med Bull; 1997 Nov; 44(5):499-521. PubMed ID: 9408736
    [No Abstract]   [Full Text] [Related]  

  • 44. Antagonism by potassium of the inhibition of (Na(+)+K+) ATPase produced by an endogenous digitalis-like compound extracted from mammalian heart.
    Castañeda-Hernández G; Flores-Murrieta FJ
    Arch Med Res; 1992; 23(1):13-7. PubMed ID: 1339224
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low-dose cardiotonic steroids increase sodium-potassium ATPase activity that protects hippocampal slice cultures from experimental ischemia.
    Oselkin M; Tian D; Bergold PJ
    Neurosci Lett; 2010 Apr; 473(2):67-71. PubMed ID: 19822191
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical and therapeutic significance of the Na+,K+ pump*.
    Clausen T
    Clin Sci (Lond); 1998 Jul; 95(1):3-17. PubMed ID: 9662481
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Direct interaction of beta-amyloid with Na,K-ATPase as a putative regulator of the enzyme function.
    Petrushanko IY; Mitkevich VA; Anashkina AA; Adzhubei AA; Burnysheva KM; Lakunina VA; Kamanina YV; Dergousova EA; Lopina OD; Ogunshola OO; Bogdanova AY; Makarov AA
    Sci Rep; 2016 Jun; 6():27738. PubMed ID: 27296892
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of the sodium potassium adenosine triphosphatase pump sensitizes cancer cells to anoikis and prevents distant tumor formation.
    Simpson CD; Mawji IA; Anyiwe K; Williams MA; Wang X; Venugopal AL; Gronda M; Hurren R; Cheng S; Serra S; Beheshti Zavareh R; Datti A; Wrana JL; Ezzat S; Schimmer AD
    Cancer Res; 2009 Apr; 69(7):2739-47. PubMed ID: 19293189
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Na,K-ATPase polypeptide upregulation responses in lens epithelium.
    Delamere NA; Manning RE; Liu L; Moseley AE; Dean WL
    Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):763-8. PubMed ID: 9538883
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Could Na,K-ATPase play a role in potassium leakage from irradiated erythrocytes?
    Maia GA; Cortes VF; Ribeiro RI; Mignaco JA; de Lima Santos H; Fontes CF; Barbosa LA
    Clin Chim Acta; 2014 Jun; 433():58-61. PubMed ID: 24607325
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dual activity of the H1-H2 domain of the (Na(+)+K+)-ATPase.
    Xu KY
    Biochem Biophys Res Commun; 2008 Dec; 377(2):469-473. PubMed ID: 18848919
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of Na+/K+-ATPase by Estradiol and IGF-1 in Cardio-Metabolic Diseases.
    Obradovic M; Stanimirovic J; Panic A; Bogdanovic N; Sudar-Milovanovic E; Cenic-Milosevic D; Isenovic ER
    Curr Pharm Des; 2017; 23(10):1551-1561. PubMed ID: 28164755
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhancing the potency of lithospermate B for inhibiting Na+/K+-ATPase activity by forming transition metal ion complexes.
    Lin NH; Chung TY; Li FY; Chen HA; Tzen JT
    Acta Pharmacol Sin; 2013 Jul; 34(7):893-900. PubMed ID: 23685954
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting oncogenic Notch signaling with SERCA inhibitors.
    Pagliaro L; Marchesini M; Roti G
    J Hematol Oncol; 2021 Jan; 14(1):8. PubMed ID: 33407740
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anticancer and Immunogenic Properties of Cardiac Glycosides.
    Schneider NFZ; Cerella C; Simões CMO; Diederich M
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29117117
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Na/K-ATPase as a target for anticancer metal based drugs: insights into molecular interactions with selected gold(iii) complexes.
    Bondžić AM; Janjić GV; Dramićanin MD; Messori L; Massai L; Parac Vogt TN; Vasić VM
    Metallomics; 2017 Mar; 9(3):292-300. PubMed ID: 28181616
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Myocardial Na,K-ATPase: Clinical aspects.
    Kjeldsen K
    Exp Clin Cardiol; 2003; 8(3):131-3. PubMed ID: 19641704
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protein Interaction and Na/K-ATPase-Mediated Signal Transduction.
    Cui X; Xie Z
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28613263
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Digitoxin-induced cytotoxicity in cancer cells is mediated through distinct kinase and interferon signaling networks.
    Prassas I; Karagiannis GS; Batruch I; Dimitromanolakis A; Datti A; Diamandis EP
    Mol Cancer Ther; 2011 Nov; 10(11):2083-93. PubMed ID: 21859838
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Experimental and theoretical insights of functionalized hexavanadates on Na
    Bošnjaković-Pavlović N; Xu X; Krstić D; Gillet JM; Wei Y; Wu P; Čolović M; Spasojević-de Biré A
    J Inorg Biochem; 2019 Sep; 198():110720. PubMed ID: 31150927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.